Dear colleague, Chronic kidney disease is a global healthcare condition associated with several comorbid conditions including cardiovascular disease, hypertension, and type 2 diabetes mellitus. Primary Care Diabetes Europe aims to undertake a project to upskill...
After careful deliberation in the executive board and considering the latest insights surrounding Covid alongside other international (geopolitical) events, it is with great regret that the PCDE board has made the difficult decision not to go ahead with an ‘in person’...
On February 16th the PCDE article“2022 update to the Position Statement by Primary Care Diabetes Europe: A Disease State Approach to the Pharmacological Management of Type 2 Diabetes in Primary Care” was published. We invite you to read the article on...
Change of name: EASD-PCDE Study Group becomes Primary Care Diabetes Europe Study Group The EASD-PCDE Study Group (in line with all Study Groups formerly associated with EASD) is to stop using “EASD” in their title, with immediate effect. PCDE respects the...
Join us at the IDC (Influenza Diabetes Community) webinar on Tuesday 16 November, organised in connection with World Diabetes Day 2021 and the theme “Access to Diabetes Care”. The programme features best practice examples on prevention from health care...
Free access to an expert-led, practical and evidence-based tool designed to help you to provide optimal management of type 2 diabetes with glucagon-like peptide-1 receptor agonists (GLP-1RAs). Guided by internationally renowned diabetes researcher Professor Melanie...
